Matinas: Positive Trial Data Has This Stock On The Move
skodonnell/iStock via Getty Images
I haven’t covered Matinas (MTNB) in a while, and recently MTNB stock has seen a spurt after publishing positive phase 2 meningitis data. Someone suggested I should take another look at MTNB, so here I am, taking another…
